# Correction by ECCO2-R of Hypercapnia in Patients With DVP in Moderate to Severe ARDS Under Protective Ventilation.

> **NCT03303807** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 8 (actual)

## Conditions studied

- Acute Respiratory Distress Syndrome
- Hypercapnia

## Interventions

- **DEVICE:** Extracorporeal CO2 removal (ECCO2-R) (PrismaLung®, Prismaflex ® Baxter)

## Key facts

- **NCT ID:** NCT03303807
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-10
- **Primary completion:** 2019-02-25
- **Final completion:** 2019-03-21
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2019-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03303807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03303807, "Correction by ECCO2-R of Hypercapnia in Patients With DVP in Moderate to Severe ARDS Under Protective Ventilation.". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03303807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*